Therapy
Mepolizumab
Neutralises IL-5 → depletes eosinophils.
In short
- 1What it is: a therapy in therapies and applications.
- 2How it connects: acts on 2 and is affected by 2 concepts — mostly 1 molecule, 1 disease, 1 trial.
- 3Where it sits: therapy on the 15-step immune chain.
What it does
Severe eosinophilic asthma, EGPA, HES.
Its connections at a glance
Each dot is a concept directly linked to Mepolizumab. Colours show the kind of concept.
Sources & evidenceloading…
Loading reviewed sources…
Graph ID I028 · concept status: established. Select any connection above to inspect evidence for that specific link.